BORON-BASED 4-HYDROXYTAMOXIFEN AND ENDOXIFEN PRODRUGS AS TREATMENT FOR BREAST CANCEREP3296300B1 · 2019
Boron-based prodrug strategy for increased bioavailability and lower-dosage requirements for drug molecules containing at least one phenol …US10112962B2 · 2018